Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

462
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
462
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

682
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
682
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

127
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
127
Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Subjective-Objective Sleep Discrepancies Among Participants With Post-acute Moderate-to-Severe Traumatic Brain Injury Following Computerized Cognitive Behavioral Therapy for Insomnia.

The Journal of head trauma rehabilitation·2026
Same author

Clinical Standardization Across a National Health System: Perspectives From the Veterans Affairs' Electronic Health Record Transition.

Medical care·2026
Same author

Clinician-documented Firearm Access and Safety Interventions for Veterans Receiving Suicide Risk Evaluation in VA Emergency Care Settings.

The western journal of emergency medicine·2026
Same author

Embedding Lived Expertise into Military and Veteran Medical Research.

Military medicine·2026
Same author

DeepSeek R1 Distilled Fails to Perform Well Against the USMLE and Other LLMs with and Without Semantics.

Studies in health technology and informatics·2026
Same author

Suicide risk and REDCap: facilitating clinical trial inclusion.

BMC psychiatry·2026

Related Experiment Video

Updated: Jul 1, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

A framework for inferring and analyzing pharmacotherapy treatment patterns.

Everett Rush1, Ozgur Ozmen2, Minsu Kim2

  • 1Oak Ridge National Laboratory, Oak Ridge, TN, USA. erush3@vols.utk.edu.

BMC Medical Informatics and Decision Making
|March 8, 2024
PubMed
Summary

Ten major pharmacotherapy patterns explain nearly 70% of antidepressant prescriptions for veterans with major depressive disorder (MDD). Dosage changes showed associations with patient outcomes, highlighting the need for careful monitoring.

Keywords:
Clinical pathwaysMajor depressive disorderProcess mining

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

Related Experiment Videos

Last Updated: Jul 1, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

Area of Science:

  • Pharmacology and Psychiatry
  • Health Informatics
  • Real-World Evidence Research

Background:

  • Understanding pharmacotherapy prescription patterns is crucial for managing major depressive disorder (MDD).
  • Real-world data and clinical pathway inference offer insights into treatment variations.
  • Previous research has not fully elucidated specific antidepressant prescribing trends in veteran populations.

Purpose of the Study:

  • To identify and describe major pharmacotherapy prescription patterns for major depressive disorder (MDD) in a veteran cohort.
  • To investigate statistical associations between these patterns and clinical outcomes using a machine learning framework.
  • To assess the utility of a clinical pathway inference framework in analyzing real-world data for MDD treatment.

Main Methods:

  • A cohort of 252,179 veterans diagnosed with major depressive disorder (MDD) from 2006-2020 was analyzed.
  • Machine learning techniques were applied to electronic health records, including antidepressant fills, emergency visits, self-harm, and mortality data.
  • The Veterans Affairs Corporate Data Warehouse provided the real-world data for this observational study.

Main Results:

  • The top ten pharmacotherapy prescription patterns accounted for 69.3% of cases initiating antidepressants at specific dosages.
  • Significant associations were observed between antidepressant dosage changes and clinical outcomes.
  • The study identified 98,417 emergency department visits, 1,016 self-harm events, and 1,507 all-cause deaths within the cohort.

Conclusions:

  • Ten major pharmacotherapy patterns were documented, representing nearly 70% of observed antidepressant prescribing for veterans with MDD.
  • While associations between antidepressant use and outcomes were found, potential confounding factors and limitations in adverse event data were noted.
  • The study demonstrates the value of the clinical pathway inference framework for understanding treatment practices and emphasizes the need for enhanced monitoring during critical treatment phases.